nifedipine has been researched along with Hypertension, Renal in 74 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Hypertension, Renal: Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the use of short-acting nifedipine for treatment of severe hypertension in children." | 7.71 | The use of short-acting nifedipine in pediatric patients with hypertension. ( Blaszak, RT; Ellis, EN; Savage, JA, 2001) |
| "We describe a case of gingival hyperplasia in a 36-year-old renal transplantation recipient treated with nifedipine for severe arterial hypertension." | 7.67 | Gingival hyperplasia by nifedipine. Report of a case. ( Bencini, PL; Crosti, C; Menni, S; Montagnino, G; Piccinno, R; Sala, F; Tarantino, A, 1985) |
| "Ten mg of Nifedipine, a Ca++ antagonist, was administered orally in 2 groups of patients; Group 1: 6 patients in hypertensive emergency and Group II: 12 patients with intractable, severe hypertension." | 7.66 | A study on the effects of nifedipine in hypertensive crises and severe hypertension. ( Hada, Y; Kamata, C; Kuramoto, K; Kuwajima, I; Matsushita, S; Murakami, M; Ueda, K, 1978) |
| "In patients with chronic renal failure, decrement in BP was 25/16 mmHg (systolic and diastolic BP, respectively)." | 6.65 | [Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension]. ( Breuer, G; Kaufmann, W; Wambach, G, 1984) |
| "When nifedipine was given to rats at a dosage of 0." | 5.26 | Inhibition of DOC-salt and adrenal-regeneration hypertension with the calcium blocker nifedipine. ( Hall, CE; Hungerford, S, 1982) |
| "Monotherapy with calcium antagonists nifedipine, foridon and verapamil hydrochloride was assessed in 46 patients with chronic glomerulonephritis and arterial hypertension by hypotensive effect and changes in systemic and renal hemodynamics, water-electrolytic balance, renin-angiotensin system." | 5.06 | [Calcium antagonists in the treatment of nephrogenic hypertension]. ( Galstian, GM; Kutyrina, IM; Rogov, VA; Tareeva, IE, 1990) |
| "Nifedipine given by the sublingual route has been used in the treatment of 30 hypertensive emergencies in 20 children suffering from renal disease." | 5.06 | Nifedipine in hypertensive crises of infants and children. ( Abu-Chaaban, M; Herkenrath, P; Krebber, J; Roth, B, 1986) |
| "To evaluate the use of short-acting nifedipine for treatment of severe hypertension in children." | 3.71 | The use of short-acting nifedipine in pediatric patients with hypertension. ( Blaszak, RT; Ellis, EN; Savage, JA, 2001) |
| "We describe a case of gingival hyperplasia in a 36-year-old renal transplantation recipient treated with nifedipine for severe arterial hypertension." | 3.67 | Gingival hyperplasia by nifedipine. Report of a case. ( Bencini, PL; Crosti, C; Menni, S; Montagnino, G; Piccinno, R; Sala, F; Tarantino, A, 1985) |
| "The new calcium antagonist felodipine with a pronounced arteriolar dilating capacity was used to treat 11 patients with severe hypertension resistant to treatment (4 with essential hypertension, 5 with renoparechymatous hypertension, 2 with renovascular hypertension)." | 3.67 | Renal effects of felodipine in hypertensive patients with reduced renal function. ( Aurell, M; Björck, S; Granérus, G; Herlitz, H, 1985) |
| "Ten mg of Nifedipine, a Ca++ antagonist, was administered orally in 2 groups of patients; Group 1: 6 patients in hypertensive emergency and Group II: 12 patients with intractable, severe hypertension." | 3.66 | A study on the effects of nifedipine in hypertensive crises and severe hypertension. ( Hada, Y; Kamata, C; Kuramoto, K; Kuwajima, I; Matsushita, S; Murakami, M; Ueda, K, 1978) |
| "We examined the progression of coronary atherosclerosis, as measured by dual-section spiral computed tomography, using the total coronary artery calcium score as a quantitative measure of the burden of atherosclerosis." | 2.71 | Accelerated coronary artery calcification in mildly reduced renal function of high-risk hypertensives: a 3-year prospective observation. ( Bursztyn, M; Grossman, E; Motro, M; Shemesh, J, 2003) |
| "Treatment with enalapril was associated with a greater reduction in albuminuria than with nifedipine in the entire patient group, and especially in those with microalbuminuria." | 2.69 | Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients. ( Chan, JC; Cheung, MY; Cheung, RC; Cockram, CS; Critchley, JA; Ko, GT; Leung, DH; Nicholls, MG; So, WY; Swaminathan, R, 2000) |
| "In patients with chronic renal failure, decrement in BP was 25/16 mmHg (systolic and diastolic BP, respectively)." | 2.65 | [Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension]. ( Breuer, G; Kaufmann, W; Wambach, G, 1984) |
| "Nifedipine treatment or removal of external calcium (Cao2+) reduced the norepinephrine-induced peak response." | 1.33 | Enhanced response to AVP in the interlobular artery from the spontaneously hypertensive rat. ( Hansen, FH; Iversen, BM; Vågnes, ØB, 2005) |
| " The hypotensive effect of YM430 reached its maximum about 2 hr after dosing and lasted for over 10 hr." | 1.30 | Hypotensive effects of YM430, a 1,4-dihydropyridine derivative, in spontaneously hypertensive rats and renal hypertensive dogs. ( Shibasaki, K; Takenaka, T; Takizawa, K; Uchida, W, 1997) |
| " No tolerance to the antihypertensive effect of KRN4884 was observed during a 15-day repeated dosing period." | 1.30 | KRN4884, a novel K channel opener: antihypertensive effects in conscious renal hypertensive dogs. ( Endo, M; Izawa, T; Izumi, H; Jinno, Y; Kawahara, J; Takeuchi, A, 1997) |
| "3-3 mg/kg), dose-response curves of the antihypertensive effect did not change and body weight gain was equal to that of the vehicle-treated group." | 1.28 | Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs. ( Haruno, A; Kanda, A; Miyake, H; Nagasaka, M, 1992) |
| "1 mg/kg) occurred during an 8-week repeated daily dosing to RHD and plasma renin activity, and aldosterone levels were not elevated during this period." | 1.28 | Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state. ( Aoki, K; Fukunari, A; Katoh, A; Nakajima, T; Setoguchi, M; Shinagawa, K; Shinohara, T; Tahara, T; Yamanaka, T; Yaoka, O, 1992) |
| "2 mg/kg/day for 20 days) chronically receiving AML, there was an enhancement of the antihypertensive effect of AML within a few days after starting chronic dosing, and thereafter a significant reduction of BP at 24 hr after dosing and constant effects of AML during subsequent treatment." | 1.28 | [Antihypertensive effects of amlodipine, a new calcium antagonist]. ( Ishiko, J; Munehasu, S; Suzuki, M; Yamanaka, K, 1991) |
| "Diabetic nephropathy is the dominant cause of hypertension in insulin-dependent diabetics, and long-term rigid antihypertensive treatment inhibits the progression of nephropathy, probably even when there is renal insufficiency." | 1.28 | The effect of antihypertensive treatment on kidney function in insulin-dependent (type I) diabetics with renal failure. ( Conde, N; Gums, G; Heinke, P; Schulz, B; Strese, J; Zander, E; Zander, G, 1990) |
| "When nitrendipine was combined with thiazides, a lowering of plasma potassium levels could be found, which, however, did not necessitate any therapy." | 1.27 | Safety aspects of long-term nitrendipine therapy. ( Corsing, C; Deck, K; Ingram, C; Stoepel, K; Vanov, SK, 1984) |
| " The long-term administration of nifedipine, 20-30 mg/kg body weight enhanced the diuretic and natriuretic response to saline loading in members of both strains." | 1.27 | Nifedipine corrects the blunted renal response to saline loading in hypertension-prone SBH rats. ( Ben-Ishay, D; Garthoff, B; Kazda, S; Mekler, J, 1987) |
| " Nisoldipine had the lowest maximum plasma concentration and the longest elimination half-life among the four 1,4-dihydropyridines, resulting in no significant difference in the area under the plasma concentration-time curve." | 1.27 | Comparative study on acute antihypertensive effects and pharmacokinetics of nisoldipine, nifedipine, nimodipine and nicardipine administered orally to conscious renal hypertensive dogs. ( Kato, H; Takata, Y, 1986) |
| "When nifedipine was given to rats at a dosage of 0." | 1.26 | Inhibition of DOC-salt and adrenal-regeneration hypertension with the calcium blocker nifedipine. ( Hall, CE; Hungerford, S, 1982) |
| "Nisoldipine has a long lasting antihypertensive action (12 hr at 0." | 1.26 | Nisoldipine (BAY K 5552), a new calcium antagonist. Antihypertensive effect in conscious, unrestrained renal hypertensive dogs. ( Knorr, A, 1982) |
| "Nitrendipine was found about 20 times more potent in its antihypertensive action than hydralazine." | 1.26 | Effect of a new calcium antagonist, nitrendipine, on blood pressure and heart rate of conscious, unrestrained dogs. ( Knorr, A; Stoepel, K, 1981) |
| " Substantial and prolonged falls in blood pressure were observed following oral dosing with 3 mg/kg of nifedipine in renal hypertensive rats, with 10 mg/kg of nifedipine in normotensive and spontaneously hypertensive rats and with 10 mg/dg of hydralazine in all three groups of animals." | 1.26 | Antihypertensive effects of nifedipine on conscious normotensive and hypertensive rats. ( Fujie, K; Kubo, T; Misu, Y; Yamashita, M, 1981) |
| " of niludipine a fall of blood pressure was marked at its peak effect attained about 45 min after dosing and lasted about 3 h." | 1.26 | Antihypertensive effect of Niludipine (Bay a 7168) on conscious renal-hypertensive dogs. ( Hiwatari, M; Taira, N, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 41 (55.41) | 18.7374 |
| 1990's | 24 (32.43) | 18.2507 |
| 2000's | 8 (10.81) | 29.6817 |
| 2010's | 1 (1.35) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xie, HH | 1 |
| Zhang, XF | 1 |
| Chen, YY | 1 |
| Shen, FM | 1 |
| Su, DF | 1 |
| Nakagawa, N | 1 |
| Fujino, T | 1 |
| Kabara, M | 1 |
| Matsuki, M | 1 |
| Chinda, J | 1 |
| Kikuchi, K | 1 |
| Hasebe, N | 1 |
| Srinivas, TR | 1 |
| Meier-Kriesche, HU | 1 |
| Kaplan, B | 1 |
| Bennett, WM | 1 |
| Bursztyn, M | 1 |
| Motro, M | 1 |
| Grossman, E | 1 |
| Shemesh, J | 1 |
| Hansen, FH | 1 |
| Vågnes, ØB | 1 |
| Iversen, BM | 1 |
| Shih, HC | 1 |
| Lee, TH | 1 |
| Chen, SC | 1 |
| Li, CY | 1 |
| Shibuya, T | 1 |
| Stoepel, K | 3 |
| Deck, K | 1 |
| Corsing, C | 1 |
| Ingram, C | 1 |
| Vanov, SK | 1 |
| Lin, CI | 1 |
| Lu, HH | 1 |
| Lin, KY | 1 |
| Ambroso, GC | 1 |
| Como, G | 1 |
| Scalamogna, A | 1 |
| Citterio, A | 1 |
| Casati, S | 1 |
| Cantaluppi, A | 1 |
| Ponticelli, C | 1 |
| Wambach, G | 1 |
| Breuer, G | 1 |
| Kaufmann, W | 1 |
| Kusano, E | 1 |
| Asano, Y | 1 |
| Takeda, K | 1 |
| Matsumoto, Y | 1 |
| Ebihara, A | 1 |
| Hosoda, S | 1 |
| Morita, T | 1 |
| Kanazawa, T | 1 |
| Ito, K | 1 |
| Nose, T | 2 |
| Hall, CE | 1 |
| Hungerford, S | 1 |
| Knorr, A | 2 |
| Eliahou, HE | 1 |
| Iaina, A | 1 |
| Schneider, R | 1 |
| Cohen, D | 1 |
| Goldfarb, D | 1 |
| Gross, M | 1 |
| Heise, A | 1 |
| Kazda, S | 2 |
| Kubo, T | 1 |
| Fujie, K | 1 |
| Yamashita, M | 1 |
| Misu, Y | 1 |
| Mulvany, MJ | 1 |
| Korsgaard, N | 1 |
| Nyborg, N | 1 |
| Ishii, H | 1 |
| Itoh, K | 1 |
| Moncica, I | 1 |
| Oh, PI | 1 |
| ul Qamar, I | 1 |
| Scolnik, D | 1 |
| Arbus, GS | 1 |
| Hebert, D | 1 |
| Balfe, JW | 1 |
| Koren, G | 1 |
| Griffin, KA | 1 |
| Picken, MM | 1 |
| Bidani, AK | 1 |
| Zucchelli, P | 2 |
| Zuccalà, A | 2 |
| Hojo, M | 1 |
| Tanaka, Y | 1 |
| Katayama, O | 1 |
| Teramoto, N | 1 |
| Wight, JP | 1 |
| Brown, CB | 1 |
| el Nahas, AM | 1 |
| Dworkin, LD | 1 |
| Benstein, JA | 1 |
| Parker, M | 1 |
| Tolbert, E | 1 |
| Feiner, HD | 1 |
| Tack, I | 1 |
| Rostaing, L | 1 |
| Tran-Van, T | 1 |
| Lloveras, JJ | 1 |
| Durand, D | 1 |
| Suc, JM | 1 |
| Ader, JL | 1 |
| de Silva, DG | 1 |
| Fernando, AJ | 1 |
| Law, F | 1 |
| Jayantha, UK | 1 |
| Grekas, D | 1 |
| Dioudis, C | 1 |
| Kalevrosoglou, I | 1 |
| Alivanis, P | 1 |
| Derveniotis, V | 1 |
| Tourkantonis, A | 1 |
| Shibasaki, K | 1 |
| Takizawa, K | 1 |
| Uchida, W | 1 |
| Takenaka, T | 1 |
| Kawahara, J | 1 |
| Jinno, Y | 1 |
| Endo, M | 1 |
| Izumi, H | 1 |
| Takeuchi, A | 1 |
| Izawa, T | 1 |
| Ikeda, Y | 1 |
| Sakemi, T | 1 |
| Yamada, M | 1 |
| Matsumoto, J | 1 |
| Yamaguchi, K | 1 |
| Callera, GE | 1 |
| Bendhack, LM | 1 |
| Chan, JC | 1 |
| Ko, GT | 1 |
| Leung, DH | 1 |
| Cheung, RC | 1 |
| Cheung, MY | 1 |
| So, WY | 1 |
| Swaminathan, R | 1 |
| Nicholls, MG | 1 |
| Critchley, JA | 1 |
| Cockram, CS | 1 |
| Blaszak, RT | 1 |
| Savage, JA | 1 |
| Ellis, EN | 1 |
| Leoncini, G | 1 |
| Martinoli, C | 1 |
| Viazzi, F | 1 |
| Ravera, M | 1 |
| Parodi, D | 1 |
| Ratto, E | 1 |
| Vettoretti, S | 1 |
| Tomolillo, C | 1 |
| Derchi, LE | 1 |
| Deferrari, G | 1 |
| Pontremoli, R | 1 |
| Nicita-Mauro, V | 1 |
| Barbera, N | 1 |
| Savica, V | 1 |
| Frisina, N | 1 |
| Ceruso, D | 1 |
| Zennaro, P | 1 |
| Borso, MT | 1 |
| Conte, A | 1 |
| Hiwatari, M | 2 |
| Satoh, K | 1 |
| Taira, N | 2 |
| Kuwajima, I | 1 |
| Ueda, K | 1 |
| Kamata, C | 1 |
| Matsushita, S | 1 |
| Kuramoto, K | 1 |
| Murakami, M | 1 |
| Hada, Y | 1 |
| Kanda, A | 1 |
| Haruno, A | 1 |
| Miyake, H | 1 |
| Nagasaka, M | 1 |
| Borghi, M | 1 |
| Fusaroli, M | 1 |
| Sasdelli, M | 1 |
| Stallone, C | 1 |
| Sanna, G | 1 |
| Gaggi, R | 1 |
| Uchiyama, M | 1 |
| Sakai, K | 1 |
| Onoyama, K | 1 |
| Nakajima, T | 1 |
| Shinohara, T | 1 |
| Yaoka, O | 1 |
| Fukunari, A | 1 |
| Shinagawa, K | 1 |
| Aoki, K | 1 |
| Katoh, A | 1 |
| Yamanaka, T | 1 |
| Setoguchi, M | 1 |
| Tahara, T | 1 |
| Abu-Romeh, SH | 1 |
| el-Khatib, D | 1 |
| Rashid, A | 1 |
| Patel, M | 1 |
| Osman, N | 1 |
| Fayyad, M | 1 |
| Scheikhoni, A | 1 |
| Higazi, AS | 1 |
| Gurgenian, SV | 1 |
| Mikaelian, ES | 1 |
| Dzhandzhapanian, AZ | 1 |
| Babaian, AS | 1 |
| Yamanaka, K | 1 |
| Suzuki, M | 1 |
| Munehasu, S | 1 |
| Ishiko, J | 1 |
| Langevitz, P | 1 |
| Buskila, D | 1 |
| Lee, P | 1 |
| Hercz, G | 1 |
| Tareeva, IE | 1 |
| Kutyrina, IM | 1 |
| Galstian, GM | 1 |
| Rogov, VA | 1 |
| Zander, E | 1 |
| Conde, N | 1 |
| Heinke, P | 1 |
| Zander, G | 1 |
| Strese, J | 1 |
| Gums, G | 1 |
| Schulz, B | 1 |
| Bencini, PL | 1 |
| Crosti, C | 1 |
| Sala, F | 1 |
| Montagnino, G | 1 |
| Tarantino, A | 1 |
| Menni, S | 1 |
| Piccinno, R | 1 |
| Spedding, M | 1 |
| DiFrancesco, GF | 1 |
| Mir, AK | 1 |
| Petty, MA | 1 |
| Berg, C | 1 |
| Gittos, M | 1 |
| Mekler, J | 1 |
| Ben-Ishay, D | 1 |
| Garthoff, B | 1 |
| Ogborn, MR | 1 |
| Crocker, JF | 1 |
| Grimm, PC | 1 |
| Schiffl, H | 1 |
| Mickisch, O | 1 |
| Schmid, M | 1 |
| Mann, JF | 1 |
| Helder, T | 1 |
| Bergen, F | 1 |
| Rauterberg, EW | 1 |
| Ritz, E | 1 |
| Plaza de los Reyes, M | 1 |
| Plaza de los Reyes, X | 1 |
| Hamilton, CA | 1 |
| Jardine, E | 1 |
| Sumner, DJ | 1 |
| Reid, JL | 1 |
| Ishii, K | 1 |
| Kano, T | 1 |
| Ando, J | 1 |
| Yoshida, H | 1 |
| Riegel, W | 1 |
| Hörl, WH | 1 |
| Heidland, A | 1 |
| Ohtsuka, M | 1 |
| Koibuchi, Y | 1 |
| Sakai, S | 1 |
| Tsujioka, K | 1 |
| Fujiwara, T | 1 |
| Ozaki, T | 1 |
| Maeda, K | 1 |
| Motoyama, I | 1 |
| Horiai, H | 1 |
| Ono, T | 1 |
| Karasawa, A | 1 |
| Ikeda, J | 1 |
| Yamada, K | 1 |
| Kubo, K | 1 |
| Oka, T | 1 |
| Nakamizo, N | 1 |
| Tasaka, K | 1 |
| Kamei, C | 1 |
| Tagami, H | 1 |
| Hokonohara, T | 1 |
| Sugimoto, Y | 1 |
| Roth, B | 1 |
| Herkenrath, P | 1 |
| Krebber, J | 1 |
| Abu-Chaaban, M | 1 |
| Marchini, F | 1 |
| Luca, C | 1 |
| Valli, L | 1 |
| Pacei, E | 1 |
| Yamaura, T | 1 |
| Kase, N | 1 |
| Kita, H | 1 |
| Uematsu, T | 1 |
| Narita, H | 1 |
| Yabana, H | 1 |
| Saso, Y | 1 |
| Suzuki, T | 1 |
| Mizobe, M | 1 |
| Nagao, T | 1 |
| Minobe, M | 1 |
| Kimura, Y | 1 |
| Fukui, H | 1 |
| Tanaka, M | 1 |
| Okamoto, M | 1 |
| Morino, A | 1 |
| Miura, A | 1 |
| Kimura, K | 1 |
| Enomoto, H | 1 |
| Takata, Y | 1 |
| Kato, H | 1 |
| Marmo, E | 1 |
| Herlitz, H | 1 |
| Aurell, M | 1 |
| Björck, S | 1 |
| Granérus, G | 1 |
| Moreira, J | 1 |
| Barata, JD | 1 |
| Olias, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Role of Renal Doppler Ultrasound in Early Detection of Acute Kidney Injury in Critically Ill Patients[NCT03902483] | 80 participants (Anticipated) | Observational | 2019-07-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for nifedipine and Hypertension, Renal
| Article | Year |
|---|---|
Pharmacological treatment of renal parenchymal hypertension.
Topics: Antihypertensive Agents; Captopril; Humans; Hypertension, Renal; Incidence; Kidney Diseases; Models, | 1994 |
14 trials available for nifedipine and Hypertension, Renal
| Article | Year |
|---|---|
Angiotensin II receptor blocker and long-acting calcium channel blocker combination therapy decreases urinary albumin excretion while maintaining glomerular filtration rate.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles | 2011 |
Accelerated coronary artery calcification in mildly reduced renal function of high-risk hypertensives: a 3-year prospective observation.
Topics: Aged; Benzothiadiazines; Calcinosis; Calcium Channel Blockers; Coronary Artery Disease; Diuretics; F | 2003 |
[Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension].
Topics: Adult; Aged; Aldosterone; Calcium Channel Blockers; Electrolytes; Female; Heart Rate; Humans; Hydroc | 1984 |
A crossover comparison of extended release felodipine with prolonged action nifedipine in hypertension.
Topics: Adolescent; Antihypertensive Agents; Child; Cross-Over Studies; Delayed-Action Preparations; Drug Ad | 1995 |
Renal functional reserve in calcium channel blocker-treated hypertensive recipients of kidney transplant.
Topics: Adult; Amino Acids; Calcium Channel Blockers; Cyclosporine; Female; Glomerular Filtration Rate; Huma | 1995 |
Experience with sublingual nifedipine in paediatric hypertensive emergencies.
Topics: Acute Disease; Administration, Sublingual; Child; Child, Preschool; Emergencies; Female; Humans; Hyp | 1995 |
Renal hemodynamics in hypertensive renal allograft recipients: effects of calcium antagonists and ACE inhibitors.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Female; G | 1996 |
Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Creatinine; Diabetes Mellitus, Type 2; | 2000 |
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blocke | 2002 |
Long-term comparison between captopril and nifedipine in the progression of renal insufficiency.
Topics: Adolescent; Adult; Aged; Blood Pressure; Captopril; Creatinine; Female; Humans; Hypertension, Renal; | 1992 |
Comparative effects of enalapril and nifedipine on renal hemodynamics in hypertensive renal allograft recipients.
Topics: Adult; Azathioprine; Cyclosporine; Enalapril; Female; Humans; Hypertension, Renal; Kidney Transplant | 1992 |
[Calcium antagonists in the treatment of nephrogenic hypertension].
Topics: Adolescent; Adult; Calcium Channel Blockers; Glomerulonephritis; Hemodynamics; Humans; Hypertension, | 1990 |
[Calcium antagonists in chronic renal failure. Undesirable effects on glomerular hemodynamics?].
Topics: Adult; Albuminuria; Calcium Channel Blockers; Enalapril; Hemodynamics; Humans; Hypertension, Renal; | 1988 |
Nifedipine in hypertensive crises of infants and children.
Topics: Adolescent; Blood Pressure; Child; Child, Preschool; Clinical Trials as Topic; Emergencies; Humans; | 1986 |
59 other studies available for nifedipine and Hypertension, Renal
| Article | Year |
|---|---|
Synergism of hydrochlorothiazide and nifedipine on blood pressure variability reduction and organ protection in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Calcium Channel Blockers; Drug Synergi | 2008 |
Response to "Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared with lisinopril".
Topics: Antihypertensive Agents; Calcium Channel Blockers; Humans; Hypertension, Renal; Kidney Transplantati | 2002 |
Enhanced response to AVP in the interlobular artery from the spontaneously hypertensive rat.
Topics: Animals; Arginine Vasopressin; Arterioles; Calcium Channel Blockers; Calcium Signaling; Hypertension | 2005 |
Anti-hypertension effects of traditional Chinese medicine ju-ling-tang on renal hypertensive rats.
Topics: Animals; Antihypertensive Agents; Biopsy; Coronary Vessels; Disease Models, Animal; Drugs, Chinese H | 2005 |
Safety aspects of long-term nitrendipine therapy.
Topics: Calcium Channel Blockers; Drug Therapy, Combination; Electrocardiography; Humans; Hydrochlorothiazid | 1984 |
Adrenergic receptors and increased reactivity of aortic smooth muscle in renal hypertensive rats.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Blood Pressure; Caffeine; Calcium; Dose-Response Relationsh | 1982 |
Slow-release nifedipine for treatment of arterial hypertension in patients with chronic renal failure.
Topics: Adult; Aged; Delayed-Action Preparations; Female; Humans; Hypertension, Renal; Kidney Failure, Chron | 1984 |
Hypotensive effect of nifedipine in hypertensive patients with chronic renal failure.
Topics: Adolescent; Adult; Calcium; Cardiac Output; Epinephrine; Female; Hemodynamics; Humans; Hypertension, | 1982 |
Antihypertensive effect of KB-944, a new calcium antagonist, in conscious normotensive and hypertensive rats.
Topics: Animals; Antihypertensive Agents; Benzothiazoles; Blood Pressure; Calcium Channel Blockers; Desoxyco | 1982 |
Inhibition of DOC-salt and adrenal-regeneration hypertension with the calcium blocker nifedipine.
Topics: Adrenal Glands; Adrenalectomy; Animals; Blood Pressure; Desoxycorticosterone; Female; Heart Rate; Hy | 1982 |
Nisoldipine (BAY K 5552), a new calcium antagonist. Antihypertensive effect in conscious, unrestrained renal hypertensive dogs.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dogs; Female; Heart Rate | 1982 |
Treatment of hypertension in dialysis and essential hypertension patients with nifedipine.
Topics: Humans; Hypertension, Renal; Kidney Failure, Chronic; Nifedipine; Pyridines; Renal Dialysis; Time Fa | 1982 |
Pharmacological studies of the antihypertensive effect of nitrendipine.
Topics: Animals; Antihypertensive Agents; Blood Flow Velocity; Calcium Channel Blockers; Cardiac Output; Dog | 1981 |
Effect of a new calcium antagonist, nitrendipine, on blood pressure and heart rate of conscious, unrestrained dogs.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Dogs; Dose-Response Relationship, Drug; Female; H | 1981 |
Antihypertensive effects of nifedipine on conscious normotensive and hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Heart Rate; Hydralazine; Hypertension; Hypertensio | 1981 |
Evidence that the increased calcium sensitivity of resistance vessels in spontaneously hypertensive rats is an intrinsic defect of their vascular smooth muscle.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium; Disease Models, Animal; Felodipine; Hyper | 1981 |
Different antihypertensive effects of nifedipine in conscious experimental hypertensive and normotensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Heart Rate; Hydralazine; Hyp | 1980 |
Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys.
Topics: Animals; Enalapril; Feedback; Hypertension, Renal; Infarction; Kidney; Male; Nephrectomy; Nifedipine | 1995 |
Acute antihypertensive effects of the new generation calcium antagonist 3-pyridine carboxylic acid 5-[(cyclopropylamino)-carbonyl]-1,4-dihydro-2,6-dimethyl-4-(2-nitrophen yl) octyl ester on conscious spontaneously hypertensive rats and renal hypertensive
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Dose-R | 1993 |
Effect of control of hypertension on progressive renal failure.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Female; Follow-Up Studies; Humans; Hypertension, Ren | 1993 |
Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Enalapril; Glomeruloscl | 1993 |
Hypotensive effects of YM430, a 1,4-dihydropyridine derivative, in spontaneously hypertensive rats and renal hypertensive dogs.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Calcium Channel | 1997 |
KRN4884, a novel K channel opener: antihypertensive effects in conscious renal hypertensive dogs.
Topics: Animals; Antihypertensive Agents; Benzopyrans; Calcium Channel Blockers; Cromakalim; Dogs; Female; H | 1997 |
Successful combined therapy of nifedipine and diltiazem for severe hypertension in a maintenance hemodialysis patient.
Topics: Calcium Channel Blockers; Diltiazem; Drug Therapy, Combination; Humans; Hypertension, Renal; Male; M | 1999 |
Contribution of sarcoplasmic reticulum calcium uptake and L-type calcium channels to altered vascular responsiveness in the aorta of renal hypertensive rats.
Topics: Animals; Aorta; Caffeine; Calcium; Calcium Channels, L-Type; Hypertension, Renal; In Vitro Technique | 1999 |
The use of short-acting nifedipine in pediatric patients with hypertension.
Topics: Adolescent; Antihypertensive Agents; Blood Pressure; Body Weight; Case-Control Studies; Child; Child | 2001 |
[Treatment of hypertensive crises with calcium antagonists].
Topics: Antihypertensive Agents; Calcium; Drug Therapy, Combination; Humans; Hypertension; Hypertension, Ren | 1978 |
[Effects of nifedipine on arterial hypertension: study of 26 cases].
Topics: Adult; Aged; Humans; Hypertension; Hypertension, Renal; Hypertension, Renovascular; Male; Middle Age | 1978 |
Antihypertensive effect of nifedipine on conscious renal-hypertensive dogs.
Topics: Animals; Antihypertensive Agents; Dogs; Female; Hemodynamics; Hydralazine; Hypertension, Renal; Male | 1979 |
Antihypertensive effect of Niludipine (Bay a 7168) on conscious renal-hypertensive dogs.
Topics: Animals; Blood Pressure; Dogs; Drug Interactions; Female; Heart Rate; Hypertension, Renal; Isoproter | 1979 |
A study on the effects of nifedipine in hypertensive crises and severe hypertension.
Topics: Adult; Aged; Blood Pressure; Calcium; Cardiac Output; Female; Humans; Hypertension; Hypertension, Re | 1978 |
Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Co | 1992 |
Rectal administration of perforated nifedipine capsules in acute severe hypertension in children.
Topics: Acute Disease; Administration, Rectal; Adolescent; Capsules; Child; Child, Preschool; Humans; Hypert | 1992 |
[Secondary kidney disease due to hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Humans; Hypertension, Renal; Nephrosclerosis; N | 1992 |
Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Benzopyrans; Blood Pressure; Cromakalim; Dog | 1992 |
Efficacy of intravenous verapamil in arterial hypertension refractory to three-step antihypertensive therapy.
Topics: Adult; Antihypertensive Agents; Clonidine; Echocardiography; Female; Hemodynamics; Humans; Hydrochlo | 1991 |
[Antihypertensive effects of amlodipine, a new calcium antagonist].
Topics: Administration, Oral; Amlodipine; Animals; Calcium Channel Blockers; Dogs; Dose-Response Relationshi | 1991 |
Scleroderma hypertensive renal crisis and the changing pattern of mortality in systemic sclerosis (scleroderma)
Topics: Adult; Captopril; Female; Humans; Hydralazine; Hypertension, Renal; Kidney; Male; Middle Aged; Minox | 1991 |
The effect of antihypertensive treatment on kidney function in insulin-dependent (type I) diabetics with renal failure.
Topics: Acute Kidney Injury; Antihypertensive Agents; Blood Pressure; Creatinine; Diabetes Mellitus, Type 1; | 1990 |
Gingival hyperplasia by nifedipine. Report of a case.
Topics: Adult; Gingival Hyperplasia; Humans; Hypertension, Renal; Kidney Transplantation; Male; Nifedipine | 1985 |
MDL 72567, a dihydropyridine calcium-antagonist, that causes vasodilation and direct sinus bradycardia.
Topics: Animals; Bradycardia; Calcium Channel Blockers; Calcium Channels; Decerebrate State; Dihydropyridine | 1987 |
Nifedipine corrects the blunted renal response to saline loading in hypertension-prone SBH rats.
Topics: Animals; Blood Pressure; Diuretics; Female; Hypertension, Renal; Kidney; Natriuresis; Nifedipine; Ra | 1987 |
Nifedipine, verapamil and cyclosporin A pharmacokinetics in children.
Topics: Child; Child, Preschool; Cyclosporins; Drug Interactions; Humans; Hypertension, Renal; Kidney Transp | 1989 |
Platelet cytosolic free calcium concentration in hypertension associated with early stage kidney disease.
Topics: Adult; Blood Platelets; Calcium; Cytosol; Drug Therapy, Combination; Female; Glomerular Filtration R | 1989 |
[Depot nifedipine in the treatment of patients with essential and renal hypertension without renal insufficiency].
Topics: Adrenergic beta-Antagonists; Adult; Delayed-Action Preparations; Drug Administration Schedule; Drug | 1985 |
The effects of calcium antagonists on blood pressure and responses to alpha-adrenoceptor agonists in hypertensive rabbits.
Topics: Adrenergic alpha-Agonists; Animals; Azepines; Blood Pressure; Calcium Channel Blockers; Drug Interac | 1987 |
Binding of [3H]nitrendipine to cardiac and cerebral membranes from normotensive and renal, deoxycorticosterone/NaCl and spontaneously hypertensive rats.
Topics: Animals; Binding Sites; Brain; Desoxycorticosterone; Hypertension; Hypertension, Renal; In Vitro Tec | 1986 |
Long-term effects of nifedipine on carbohydrate and lipid metabolism in hypertensive hemodialyzed patients.
Topics: Adult; Blood Glucose; Cholesterol; Citrates; Citric Acid; Female; Glucagon; Humans; Hypertension, Re | 1986 |
Effects of nilvadipine on the cardiovascular system in experimental animals.
Topics: Animals; Calcium; Calcium Channel Blockers; Coronary Disease; Coronary Vessels; Dogs; Female; Guinea | 1988 |
Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in conscious, renal-hypertensive dogs.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Chemical Phenomena; Chem | 1988 |
Antihypertensive effects of nisoldipine and reference drugs in certain types of hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Hypertension; Hypertension, | 1987 |
[Anti-hypertensive activity of P0285 and nifedipine in conscious normotensive rats and in rats with spontaneous, renal and desoxycorticosterone acetate-induced hypertension].
Topics: Animals; Calcium Channel Blockers; Desoxycorticosterone; Dihydropyridines; Heart Rate; Hypertension; | 1987 |
Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
Topics: Anesthesia, General; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dih | 1986 |
Hypotensive action of diltiazem in conscious renal hypertensive dogs: comparison with nifedipine and interaction with pindolol.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Diltiazem; Dogs; Electrocardiography; Heart Rate; | 1986 |
Antihypertensive effects of a new dihydropyridine calcium antagonist.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cats; Dihydropyridines; | 1986 |
Comparative study on acute antihypertensive effects and pharmacokinetics of nisoldipine, nifedipine, nimodipine and nicardipine administered orally to conscious renal hypertensive dogs.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Dogs; Dose-Response Relation | 1986 |
On the mechanism of the anti-hypertensive effect of Ca++-blockers.
Topics: Anesthesia; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dogs; Heart | 1986 |
Renal effects of felodipine in hypertensive patients with reduced renal function.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Felodipine; Female; Glomerular Filtration Rate | 1985 |
Antihypertensive action of calcium blockade in hypertensive patients with chronic renal disease.
Topics: Adult; Aged; Blood Pressure; Chronic Disease; Drug Therapy, Combination; Female; Humans; Hypertensio | 1985 |